Gene Therapy Market $ 17.2 Billion by 2026 – Global Trends, Share Analysis, Leading Players, Business Opportunities
In February 2022, Sarepta Therpeutics (US) announced a collaboration to use GenEdit’s NanoGalaxy platform and Sarepta’s gene editing technology to develop gene editing therapeutics to treat neuromuscular diseases.
View full press release